The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Lucinda M GruberSina JasimAllison Ducharme-SmithToby WeingartenWilliam F YoungIrina BancosPublished in: The Journal of clinical endocrinology and metabolism (2021)
Metyrosine is a safe addition to traditional alpha- and beta-adrenergic blockade and should be considered in those patients with PPGL at high risk for acute release of catecholamines.